Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. (HEPA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HEPA · as of Jun 9, 2026
Key Statistics
Explore Hepion Pharmaceuticals, Inc. Data
hepa stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 33.3%
The HEPA analyst consensus is Hold, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $70.00, representing +114654.10% upside from the current price of $0.06.
Competitors & Peers
hepa competitorsHEPA
CDT
COCH
ENVB
LIXT
NIVFStock Performance
Full HistoryAbout Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cycl…
what is hepion pharmaceuticals, inc. · hepa stock overview · hepion pharmaceuticals, inc. company profile · who is hepion pharmaceuticals, inc. ceo · hepa OTC · hepion pharmaceuticals, inc. headquarters · hepion pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Hepion Pharmaceuticals, Inc. (HEPA) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 10, 2014. As of the latest trading session, HEPA stock price is $0.06, with a market capitalization of $710,266. The stock has returned -3.17% over the past 12 months and +1.67% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Hepion Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $70.00. In fiscal year 2025, Hepion Pharmaceuticals, Inc. reported revenue of — and net income of -$8.3M. For detailed data — including Hepion Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hepion Pharmaceuticals, Inc. (HEPA) stock price is $0.06. The stock is traded on OTC under the ticker symbol HEPA. The 52-week range is $0.03 – $0.25.